Post by
FarmerBetty on Oct 18, 2022 4:27pm
Acumen Pharma
A friend asked me why are people not aware of the timeline it takes to acquire phase 1 results in the clinic? Acumen is the company Promis had on it's corporate presentations until the bottom fell out off the Nasdaq.
ACU193 - Is the first immunotherapy drug candidate to enter the clinic that was developed to target toxic ABO's. Closest technology to Promis! Highlights off of Acumen's website.
Aug 16,2021- We anticipate study ACU-001 recruitment and cohort progression will allow us to provide topline results.....by year end 2022.
Oct 7, 2021- Accumen announces first patient dose.
Mar 28, 2022- Currently enrolling topline results now expected first half of 2023.
Clinical Trials. Gov. Recruitment status : Recruiting, first posted Jun 18,2021, Last updated Oct 10, 2022.
Estimated enrollment - 62 participants
Actual study start: Jun 21, 2021
Estimated primary completion date: Mar 2023
Estimated study completion date: Jun 2023
Comment by
retiredcop on Oct 18, 2022 4:49pm
First doses willgoto paid individuals...usually university or med students